Novartis Investor Presentation

New Novartis: Our strategy Our focus Our priorities > Conclusion Abbreviations Key takeaways 1 Transforming to a pure-play IM company 2 Focusing strategy on 5 core TAs, technology platforms and the US 3 Establishing 8 in-market brands with multi-bn $ potential 4 Prioritizing pipeline to high-value NMES in our 5 core TAS 5 Continuing to deliver improved financials 33 Novartis Investor Presentation | September 22, 2022 6 Continuing with shareholder friendly capital allocation 7 Strengthening foundations – ESG and culture 1 | NOVARTIS | Reimagining Medicine

View entire presentation